A clinical evaluation of chlorphenoxamine with caffeine in the treatment of Parkinson's disease, including a comparison with methixene.
D000328:Adult; D000368:Aged; D002110:Caffeine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005021:Ethylamines / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*
D005021:Ethylamines; D010276:Parasympatholytics; D002110:Caffeine